Bain Capital's full shareholding in Tower, comprising 68.3 million shares, has been successfully allocated to investors.
Tower's trading halt application, submitted on March 30, 2025, has been lifted, allowing for the resumption of trading on the NZX and ASX.
The trading halt was initially requested pending the completion of the sell-down.
See more
Kernel Wealth's test share buyers have been piling into Nvidia, Apple and Google.
Investors heaved a sigh of relief as NZ shares responded to Trump's change of heart.
Pacific Edge shares fell 26% to 8.4 cents on Monday, but “all is not necessarily lost”, said Forsyth Barr analysts.A local coverage determination in the United States means the company will no longer receive reimbursement for its Cxbladder tests from Medicare. Centres for Medicar...
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details
